Abstract:In this study, four novel series of 4‐phenyl‐1H‐1,2,4‐triazol‐5(4H)‐one derivatives containing triazole or piperazine moieties were designed, synthesized, and evaluated for negative inotropic activity by measuring the left atrium stroke volume in isolated rabbit heart preparations. Almost all of the compounds showed an ability to moderate the cardiac workload by decreasing the heart rate and contractility. Among them, 7h was found to be the most potent with a change in stroke volume of −48.22 ± 0.36% at a concentration of 3 × 10−5 mol/L (metoprolol: −9.74 ± 0.14%). The cytotoxicity of these compounds was evaluated using the human cervical cancer cell line HeLa, the liver cancer cell line Hep3B, and the human normal hepatic cell line LO2. A preliminary study of the mechanism of action for the compound 7h on the regulation of atrial dynamics with ATP‐sensitive K+ channel and L‐type Ca2+ channel blockers glibenclamide and nifedipine was performed in the isolated perfused beating rabbit atria.

Synthesis of 2-(4-substitutedbenzylpiperazin-1-yl)-n-(2-oxo-2,3-dihydrobenzooxazol-6-yl)acetamides As Inotropic Agents.

Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-n-(3,4-dihydro-3-oxo-2h-benzo[b][1,4]oxazin-7-yl)acetamides and Their Positive Inotropic Evaluation.

Synthesis and In-Vitro Inotropic Evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-n-(4,5-dihydro-1-phenyl-[1,2,4 ]Triazolo[4,3-A]quinolin-7-yl)acetamides

Synthesis of 2-(4-substituted Benzyl-1,4-Diazepan-1-Yl)-N-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Oxazin-7- Yl)Acetamides and Their Positive Inotropic Evaluation

Synthesis of 2-(4-substitutedbenzyl-[1,4]diazepan-1-yl)-n-(1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides As Inotropic Agents.

Synthesis and Positive Inotropic Evaluation of 2-(4-substituted Benzyl-1,4-Diazepan-1-Yl)-N-(5-Bromoquinoxalin-6-Yl)Acetamides

Synthesis and Positive Inotropic Evaluation of N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides Bearing Piperazine and 1,4-Diazepane Moieties.

Synthesis and Positive Inotropic Activity of [1,2,4]Triazolo[4,3-A] Quinoxaline Derivatives Bearing Substituted Benzylpiperazine and Benzoylpiperazine Moieties.

Synthesis and biological evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties as positive inotropic agents.

Synthesis of new triazole acetamides with inotropic effects.

Synthesis and Positive Inotropic Evaluation of [1,2,4]Triazolo[3,4-A]phthalazine and Tetrazolo[5,1-A]phthalazine Derivatives Bearing Substituted Piperazine Moieties

ChemInform Abstract: Synthesis and Positive Inotropic Evaluation of (e)‐2‐(4‐cinnamylpiperazin‐1‐yl)‐n‐(1‐substituted‐4,5‐dihydro [1,2,4]Triazolo[4,3‐a]quinolin‐7‐yl)acetamides.

Synthesis and positive inotropic activity of N-(4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-2-(piperazin-1-yl)acetamide derivatives.

Synthesis and inotropic evaluation of 1-substituted-N-(4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)piperidine-4-carboxamides.

Synthesis and Positive Inotropic Evaluation of 1-(Benzylamino)-3-(4,5-di-hydro[1,2,4]trizaolo[4,3-a]quinolin-7-yloxy)propan-2-ol Derivatives

Design, Synthesis, and Negative Inotropic Evaluation of 4‐phenyl‐1h‐1,2,4‐triazol‐5(4h)‐one Derivatives Containing Triazole or Piperazine Moieties

ChemInform Abstract: Synthesis and in Vitro Inotropic Evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-n-(4,5-dihydro-1-phenyl [1,2,4]Triazolo[4,3-A]quinolin-7-yl)acetamides.

Synthesis and Negative Inotropic Effects Evaluation of 7-Substituted-4,5-dihydro-[1,2,4]oxadiazolo[4,3-a]quinolin-1-ones

ChemInform Abstract: Synthesis of New Triazole Acetamides with Inotropic Effects.

The Regulating Inotropic Activity of 7-Substituted-Oxy-Benzo[4,5]Thiazolo[2,3-c][1,2,4]Triazole

The regulating inotropic activity of 6-substituted-oxy-[1,2,4]triazolo[3,4-a]phthalazine